Literature DB >> 28840576

Demographic and Psychosocial Influences on Treatment Adherence for Children and Adolescents with PKU: A Systematic Review.

Emma Medford1,2, Dougal Julian Hare3, Anja Wittkowski4,5.   

Abstract

Phenylketonuria (PKU) is a rare genetic disorder in which the amino acid phenylalanine cannot be sufficiently metabolised. Although a build-up of phenylalanine causes irreversible cognitive impairment, this can be prevented through a strict, lifelong diet restricted in natural protein. Despite the severe consequences of poor metabolic control, many children and adolescents have phenylalanine levels above their recommended limits. This systematic review was the first to examine studies reporting demographic and/or psychosocial influences on blood phenylalanine levels, with the aim to identify factors that were robustly linked with metabolic control. Four electronic databases were searched, yielding 1,808 articles. Articles were included if they reported a statistical examination of the association between one or more demographic or psychosocial factor(s) and metabolic control (as measured by blood phenylalanine concentration) for children and adolescents with PKU. Twenty-nine studies were selected for inclusion, which examined a range of child, parent and family factors related to blood phenylalanine levels. The most reproducible association was with child age, with metabolic control worsening with increasing age. This suggests that interventions promoting treatment adherence would be particularly beneficial for adolescents. There was a paucity of studies in some areas, and the quality of included studies varied; therefore, the conclusions of this review are preliminary. Research recommendations focus on promoting the growth of the evidence-base to support clinical practice.

Entities:  

Keywords:  Adherence; Children; Demographic; Metabolic; Phenylketonuria; Psychosocial

Year:  2017        PMID: 28840576      PMCID: PMC5953888          DOI: 10.1007/8904_2017_52

Source DB:  PubMed          Journal:  JIMD Rep        ISSN: 2192-8304


  52 in total

1.  Phenylketonuria in adulthood: a collaborative study.

Authors:  R Koch; B Burton; G Hoganson; R Peterson; W Rhead; B Rouse; R Scott; J Wolff; A M Stern; F Guttler; M Nelson; F de la Cruz; J Coldwell; R Erbe; M T Geraghty; C Shear; J Thomas; C Azen
Journal:  J Inherit Metab Dis       Date:  2002-09       Impact factor: 4.982

2.  PKU: high plasma phenylalanine concentrations are associated with increased prevalence of mood swings.

Authors:  Karen Anjema; Margreet van Rijn; Paul H Verkerk; Johannes G M Burgerhof; M Rebecca Heiner-Fokkema; Francjan J van Spronsen
Journal:  Mol Genet Metab       Date:  2011-06-02       Impact factor: 4.797

3.  Quality of dietary control in phenylketonuric patients and its relationship with general intelligence.

Authors:  M A Vilaseca; N Lambruschini; Lilianne Gómez-López; A Gutiérrez; E Fusté; R Gassió; R Artuch; J Campistol
Journal:  Nutr Hosp       Date:  2010 Jan-Feb       Impact factor: 1.057

4.  Psychiatric symptoms and disorders in phenylketonuria.

Authors:  V L Brumm; D Bilder; S E Waisbren
Journal:  Mol Genet Metab       Date:  2010       Impact factor: 4.797

5.  Nutrient intake and food consumption of adolescents and young adults with phenylketonuria.

Authors:  B Schulz; H J Bremer
Journal:  Acta Paediatr       Date:  1995-07       Impact factor: 2.299

6.  Bone mineral status in children with phenylketonuria under treatment.

Authors:  A Al-Qadreh; K H Schulpis; H Athanasopoulou; C Mengreli; A Skarpalezou; I Voskaki
Journal:  Acta Paediatr       Date:  1998-11       Impact factor: 2.299

Review 7.  Adherence issues in inherited metabolic disorders treated by low natural protein diets.

Authors:  A MaCdonald; M van Rijn; F Feillet; A M Lund; L Bernstein; A M Bosch; M Gizewska; F J van Spronsen
Journal:  Ann Nutr Metab       Date:  2012-12-03       Impact factor: 3.374

8.  Predictors of mean phenylalanine levels during the first five years of life in patients with phenylketonuria who were treated early. Dutch National PKU Steering Committee.

Authors:  P H Verkerk; F J van Spronsen; M van Houten; G P Smit; R C Sengers
Journal:  Acta Paediatr Suppl       Date:  1994-12

9.  Knowledge, compliance and serum phenylalanine concentrations in adolescents and adults with phenylketonuria and the effect of a patient-focused educational resource.

Authors:  S J Durham-Shearer; P A Judd; K Whelan; J E Thomas
Journal:  J Hum Nutr Diet       Date:  2008-10       Impact factor: 3.089

10.  Clinical research for rare disease: opportunities, challenges, and solutions.

Authors:  Robert C Griggs; Mark Batshaw; Mary Dunkle; Rashmi Gopal-Srivastava; Edward Kaye; Jeffrey Krischer; Tan Nguyen; Kathleen Paulus; Peter A Merkel
Journal:  Mol Genet Metab       Date:  2008-11-13       Impact factor: 4.797

View more
  7 in total

1.  Parenting a Child with Phenylketonuria: An Investigation into the Factors That Contribute to Parental Distress.

Authors:  Olivia Ambler; Emma Medford; Dougal J Hare
Journal:  JIMD Rep       Date:  2018-04-20

2.  Exploring the Barriers and Motivators to Dietary Adherence among Caregivers of Children with Disorders of Amino Acid Metabolism (AAMDs): A Qualitative Study.

Authors:  Jing Ying Lim; Roslee Rajikan; Noh Amit; Nazlena Mohamad Ali; Haslina Abdul Hamid; Huey Yin Leong; Maslina Mohamad; Bi Qi Koh; Aini Musa
Journal:  Nutrients       Date:  2022-06-18       Impact factor: 6.706

3.  Parenting a Child with Phenylketonuria (PKU): an Interpretative Phenomenological Analysis (IPA) of the Experience of Parents.

Authors:  Katie Carpenter; Anja Wittkowski; Dougal J Hare; Emma Medford; Stewart Rust; Simon A Jones; Debbie M Smith
Journal:  J Genet Couns       Date:  2018-02-21       Impact factor: 2.537

4.  Living with phenylketonuria in adulthood: The PKU ATTITUDE study.

Authors:  Chiara Cazzorla; Giulia Bensi; Giacomo Biasucci; Vincenzo Leuzzi; Filippo Manti; Antonella Musumeci; Francesco Papadia; Vera Stoppioni; Albina Tummolo; Marcella Vendemiale; Giulia Polo; Alberto Burlina
Journal:  Mol Genet Metab Rep       Date:  2018-07-11

5.  Quality assessment with diverse studies (QuADS): an appraisal tool for methodological and reporting quality in systematic reviews of mixed- or multi-method studies.

Authors:  Reema Harrison; Benjamin Jones; Peter Gardner; Rebecca Lawton
Journal:  BMC Health Serv Res       Date:  2021-02-15       Impact factor: 2.655

6.  Beneficial Effects of Slow-Release Large Neutral Amino Acids after a Phenylalanine Oral Load in Patients with Phenylketonuria.

Authors:  Iris Scala; Daniela Concolino; Anna Nastasi; Giulia Esposito; Daniela Crisci; Simona Sestito; Stefania Ferraro; Lucia Albano; Margherita Ruoppolo; Giancarlo Parenti; Pietro Strisciuglio
Journal:  Nutrients       Date:  2021-11-10       Impact factor: 5.717

7.  The Impact of a Slow-Release Large Neutral Amino Acids Supplement on Treatment Adherence in Adult Patients with Phenylketonuria.

Authors:  Alessandro P Burlina; Chiara Cazzorla; Pamela Massa; Christian Loro; Daniela Gueraldi; Alberto B Burlina
Journal:  Nutrients       Date:  2020-07-14       Impact factor: 5.717

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.